Stocks to buy

Income investors should embrace higher yields while interest rates remain at (hopefully) their peak. With one Fed rate cut likely in the cards later this year, we’ve pretty much seen a “reset” of expectations of sorts. Indeed, we can live with another few months of elevated rates, with one cut by the year’s close. There’s

Intel (NASDAQ:INTC) remains poised to generate higher-than-expected revenue from its recently released Gaudi 3 AI chips. Moreover, the firm is benefiting from significant increases in notebook sales now, while it should get a big lift from strong AI PC sales and its chip manufacturing business in the longer term. Since the valuation of Intel stock

After soaring throughout most of the week, the stock market is back to trading sideways once again. But we don’t think this weakness will last – because in our view, the Federal Reserve will surely cut rates by September. And anticipation of that first Fed cut will lead stocks to rally strongly throughout the summer. 

One can barely go far today without seeing or hearing the term AI. Artificial intelligence, or AI, has grown exponentially. Many of the world’s greatest minds have touted AI as the next great technology and a moment reminiscent of the invention of the internet. There you have it, then, investors. We can make ourselves available

Looking for stocks to 20X within a decade isn’t as easy as it once was. A few years ago, during the ZIRP era, it seemed simpler. Back then, investors could choose stocks that promised significant growth, regardless of current profitability, and were bolstered by ample cheap debt. This strategy paid off for companies like Uber

Growth investing has been incredibly rewarding for investors who punched their ticket well ahead of the artificial intelligence (AI) boom. AI hype is giving yet another shot in the arm to the tech sector. After an incredible Worldwide Developers Conference (WWDC) hosted by Apple (NASDAQ:AAPL), the sector found itself up close to 10% in the

It’s not every day when a stock generates triple-digit returns. Some investors dig through hundreds of stocks to discover which ones have the potential to deliver triple-digit returns. It takes a lot of research to find stocks with that type of potential, but even then, not all of them live up to expectations. Investors should

Blue-chip stocks are always the best choice if you’re looking for big gains without loading up on speculative stocks. The oversold blue-chip stocks to buy provide more consistent upside for investors, with strong long-term growth opportunities.  Most blue-chip stocks have proved themselves in terms of returns and long-term growth trajectories. After years of investing, the

Dividend income, particularly when it is reinvested, can really add up over time. Many of the world’s best investors are focused on dividend payouts and use them to build their portfolio. Look at Warren Buffett’s investment in Coca-Cola (NYSE:KO). The Oracle of Omaha will earn $784 million this year in dividend payments on the 400

As much as the market has had impressive gains, the tide hasn’t lifted all boats. Some stocks are languishing near lows due to their short-term challenges. However, there are some rough diamonds that just need a little polishing for their value to shine through. Indeed, these stocks at 52-week lows for rebound present an attractive

Fundamentally, biotech stocks to buy operate on a clear and unavoidable narrative: wealth means nothing without health. You hear various stories about extremely wealthy tycoons throwing all kinds of money, not just for lifesaving procedures but in more superficial efforts such as maintaining youth and vitality. It comes down to the same theme. Good health

Low-priced stocks under $10 can be explosively awarding. That is, if you spot the right one at the right time with the right catalyst.  Look at Advanced Micro Devices (NASDAQ:AMD). Not too long ago, AMD traded at about $10 a share as chip demand began to heat back up. Then, as the artificial intelligence (AI)

Nvidia (NASDAQ:NVDA) recently completed its much-anticipated 10-for-1 stock split. That means traders who held one share of Nvida at around $1,200 per share now own ten Nvidia shares trading at around $120 per share. Investors have started considering other stocks to buy after Nvidia’s stock split. Given the reduced barrier for buying whole shares, it

This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here. In 2016, Warren Buffett’s Berkshire Hathaway (NYSE:BRK-A, NYSE:BRK-B) bought almost 10 million Apple (NASDAQ:AAPL) shares. The smartphone maker’s stock had declined 14%, pricing them at just 11 times expected earnings. Apple had become one

Not all dividend stocks are worthy of a royal title like Dividend Duke (a completely made-up term, by the way). Indeed, there are Dividend Kings who have raised dividends by at least 50 straight years, a feat that’s impressive but quite hard to do. Not because dividend payers can’t stand up to challenges (like recessions)

Today, we will explore three artificial intelligence (AI) stocks challenging Nvidia (NASDAQ:NVDA), each poised with distinct strengths and growth potential for investors. With its cutting-edge GPUs and AI hardware, Nvidia has become the dominant force in the AI space. As a result, NVDA shares are up over 150% year-to-date (YTD). According to the latest McKinsey

Building a solid retirement portfolio to carry you through your golden years requires just a few key ingredients like income reliability, dividend growth and exceptional yield. That’s because retirement is not the time to take fliers on penny stocks. You want solid companies with a proven track record of paying a dividend that is well-supported

Blockchain stocks and the industry are growing so quickly that investors can become multimillionaires if they time their bets right for events like the fourth Bitcoin (BTC-USD) split and the approval of Bitcoin ETF filings. What’s more, the ongoing interest in blockchain, illustrated by institutional money, is helping to legitimize the sector, which is making

Ozempic and Wegovy (semaglutide for diabetes and weight loss, respectively) are popular weight-loss drugs that have taken the world by storm. Indeed, the craze is showing no signs of slowing down as more supply of GLP-1 receptor agonists comes online to meet blistering demand. Though demand is showing no signs of slowing, there’s already a

Stocks are inherently enticing. First, they let you purchase the power to have a say in the operations of a company through voting. Then you can receive payouts through dividends. And finally, you profit off of your original investment by selling your stock. However, for everyday investors, putting a few hundred dollars into a company